IMMUCELL CORPORATION - COMMON STOCK
5.1490
19-2月-25 16:45:00
15 分の遅延
株式
+0.1290
+2.57%
本日の幅
4.8400 - 5.1700
ISIN
N/A
ソース
NASDAQ
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023
11 5 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023
04 5 2023 06:30:23 提供 Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023
05 4 2023 16:05:35 提供 Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022
21 2 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022
15 2 2023 11:55:13 提供 Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022
09 1 2023 16:05:06 提供 Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022
21 11 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022
10 11 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022
05 10 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
14 9 2022 17:01:34 提供 Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022
11 8 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
04 8 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
27 7 2022 20:05:00 提供 Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
07 7 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
19 5 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022
12 5 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022
10 5 2022 10:00:00 提供 Nasdaq GlobeNewswire
-
UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
05 5 2022 13:17:59 提供 Nasdaq GlobeNewswire
-
Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
05 5 2022 11:17:08 提供 Nasdaq GlobeNewswire
-
ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022
11 4 2022 16:05:00 提供 Nasdaq GlobeNewswire